The Veteran's claim for compensation under 38 U.S.C. § 1151 for vision loss was denied because the VA care did not cause his additional disability of blurred vision and vision loss, which were related to his service-connected psychiatric disorder (primarily Seroquel or Paxil). The TDIU claim was granted.
The deciding factor: The Veteran's vision problems were found to be caused by his service-connected psychiatric disorders rather than VA care, thus failing the causation requirement for compensation under 38 U.S.C. § 1151.
- Claimed conditions
- Diabetic Retinopathy, Glaucoma
- How they argued it
- Secondary to another service-connected condition
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- October 27, 2022
- Citation
- 22060393
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22060393.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's service-connected glaucoma has rendered him unable to secure or follow substantially gainful employment on an extra-schedular basis, effective September 1, 2020.
- Whole decision: Remanded (sent back)
The Board has granted an earlier effective date of December 12, 2017 for the award of service connection for dry eye syndrome. The issue of entitlement to an initial compensable rating for dry eye syndrome is remanded.
- Whole decision: Granted
The Veteran's coronary artery disease is rated at 100 percent effective April 13, 2023.,The Veteran's other trauma and stressor related disorder is rated at 70 percent effective April 13, 2023.
- Whole decision: Remanded (sent back)
The Board has remanded the claim of entitlement to compensation benefits under 38 U.S.C. § 1151 for glaucoma due to inadequate development and reasoning in the previous decision.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.